Hücre Ölümünün Tersine Çevrilmesi: Anastaz
Özet
Geleneksel olarak tek yönlü ve geri dönüşümsüz kabul edilen programlı hücre ölümü süreçlerinin (apoptoz, nekroptoz, piroptoz ve ferroptoz), hücrelerin ileri ölüm basamaklarından bile geri dönebileceğini gösteren güncel bulgularla esnetildiği görülmektedir. Eski Yunancada "yeniden doğuş" anlamına gelen ve ilk kez 2009 yılında tanımlanan "anastaz" fenomeni, hücrelerin ölüm uyaranının ortamdan uzaklaştırılması ya da belirli inhibitörlerin eklenmesiyle hayatta kalma ve proliferasyon yeteneklerini yeniden kazanması sürecini ifade eder. Apoptozda otofaji, ısı şoku proteinleri ve hücre döngüsü arrest genleri bu geri dönüşü desteklerken; nekroptoz ve piroptozda ESCRT-III protein kompleksi membran bütünlüğünü yeniden sağlayarak kritik bir rol üstlenir. Ferroptozda ise ek olarak glutatyon veya ferrostatin-1 gibi moleküllerin varlığı gerekmektedir. Evrimsel bir hayatta kalma mekanizması olan anastaz; sınırlı çoğalan nöron, kardiyomiyosit ve hepatosit gibi hücrelerin korunmasında terapötik potansiyel taşırken, hasarlı ve mutasyonlu hücrelerin sağ kalmasını sağlayarak onkojenik dönüşüme, kanserde ilaç direncine ve nükse yol açabilmektedir. Sonuç olarak, anastazı düzenleyen genetik ve epigenetik mekanizmaların tam olarak aydınlatılması, klinik yaklaşımların geliştirilmesi için kritik önemdedir.
Programmed cell death processes (apoptosis, necroptosis, pyroptosis, and ferroptosis), traditionally considered unidirectional and irreversible, have been challenged by recent findings showing that cells can recover even from advanced stages of death. The phenomenon of "anastasis," meaning "rebirth" in ancient Greek and first defined in 2009, refers to the process where cells regain their survival and proliferation capabilities upon removal of the death stimulus or the addition of specific inhibitors. While autophagy, heat shock proteins, and cell cycle arrest genes support this reversal in apoptosis, the ESCRT-III protein complex plays a critical role in restoring membrane integrity during necroptosis and pyroptosis. In ferroptosis, the presence of molecules targeting iron mechanisms, such as glutathione or ferrostatin-1, is additionally required. As an evolutionary survival mechanism, inducing anastasis holds therapeutic potential for protecting cells with limited proliferation, such as neurons, cardiomyocytes, and hepatocytes; however, it can also promote oncogenic transformation, drug resistance, and recurrence in cancer by allowing damaged and mutated cells to survive. Consequently, fully elucidating the genetic and epigenetic mechanisms regulating anastasis remains critical for developing protective or inhibitory therapeutic approaches.
Referanslar
Galluzzi L, Vitale I, Aaronson SA, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018; 25(3): 486-541. doi: 10.1038/s41418-017-0012-4.
Tang HL, Yuen KL, Tang HM, et al. Reversibility of apoptosis in cancer cells. Br J Cancer. 2009; 100(1):118-122. doi:10.1038/sj.bjc.6604802.
Tang HL, Tang HM, Mak KH, et al. Cell survival, DNA damage, and oncogenic transformation after a transient and reversible apoptotic response. Mol Biol Cell. 2012; 23(12): 2240-2252. doi:10.1091/mbc.E11-11-0926.
Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972; 26(4): 239-257. doi:10.1038/bjc.1972.33.
D'Arcy MS. Cell death: a review of the major forms of apoptosis, necrosis and autophagy. Cell Biol Int. 2019; 43(6): 582-592. doi: 10.1002/cbin.11137.
Tang HM, Tang HL. Anastasis: recovery from the brink of cell death. R Soc Open Sci. 2018; 5(9): 180442. Published 2018 Sep 19. doi:10.1098/rsos.180442.
Tang HL, Tang HM, Hardwick JM, et al. Strategies for tracking anastasis, a cell survival phenomenon that reverses apoptosis. J Vis Exp. 2015; (96): 51964. Published 2015 Feb 16. doi:10.3791/51964
Tang HM, Talbot CC Jr, Fung MC, et al. Molecular signature of anastasis for reversal of apoptosis. F1000Res. 2017; 6:43. Published 2017 Jan 13. doi:10.12688/f1000research.10568.2.
Dhuriya YK, Sharma D. Necroptosis: a regulated inflammatory mode of cell death. J Neuroinflammation. 2018; 15(1): 199. Published 2018 Jul 6. doi:10.1186/s12974-018-1235-0.
Galluzzi L, Kepp O, Chan FK, Kroemer G. Necroptosis: Mechanisms and Relevance to Disease. Annu Rev Pathol. 2017; 12:103-130. doi:10.1146/annurev-pathol-052016-100247.
Gong YN, Guy C, Olauson H, et al. ESCRT-III Acts Downstream of MLKL to Regulate Necroptotic Cell Death and Its Consequences. Cell. 2017; 169(2): 286-300.e16. doi:10.1016/j.cell.2017.03.020.
Gong YN, Crawford JC, Heckmann BL, et al. To the edge of cell death and back. FEBS J. 2019; 286(3): 430-440. doi:10.1111/febs.14714.
Shi J, Gao W, Shao F. Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death. Trends Biochem Sci. 2017; 42(4): 245-254. doi: 10.1016/j.tibs.2016.10.004. Epub 2016 Dec 5. PMID: 27932073.
Yu P, Zhang X, Liu N, et al. Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther. 2021; 6(1):128. doi: 10.1038/s41392-021-00507-5.
Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021; 22(4): 266-282. doi: 10.1038/s41580-020-00324-8.
Xie Y, Hou W, Song X, et al. Ferroptosis: process and function. Cell Death Differ. 2016; 23(3): 369-379. doi:10.1038/cdd.2015.158.
Tang HM, Tang HL. Cell recovery by reversal of ferroptosis. Biol Open. 2019; 8(6): bio043182. Published 2019 Jun 11. doi:10.1242/bio.043182.
Inceboz M, Goker Bagca B, Caner A, et al. Anastasis in Glioblastoma, Brain Cancer Stem, and Brain Stem Cells. JBACHS. 2021; 5(1): 14-21.
